Preparation and Evaluation of Inhalable Sustained Release Sildenafil Citrate Solid Lipid Microparticles Dispersions

α
A. A.Yas
A. A.Yas
σ
Ali Al - Jipouri
Ali Al - Jipouri
α University of Tikrit

Send Message

To: Author

Preparation and Evaluation of Inhalable Sustained Release Sildenafil Citrate Solid Lipid Microparticles Dispersions

Article Fingerprint

ReserarchID

PDDTM44QJD

Preparation and Evaluation of Inhalable Sustained Release Sildenafil Citrate Solid Lipid Microparticles Dispersions Banner

AI TAKEAWAY

Connecting with the Eternal Ground
  • English
  • Afrikaans
  • Albanian
  • Amharic
  • Arabic
  • Armenian
  • Azerbaijani
  • Basque
  • Belarusian
  • Bengali
  • Bosnian
  • Bulgarian
  • Catalan
  • Cebuano
  • Chichewa
  • Chinese (Simplified)
  • Chinese (Traditional)
  • Corsican
  • Croatian
  • Czech
  • Danish
  • Dutch
  • Esperanto
  • Estonian
  • Filipino
  • Finnish
  • French
  • Frisian
  • Galician
  • Georgian
  • German
  • Greek
  • Gujarati
  • Haitian Creole
  • Hausa
  • Hawaiian
  • Hebrew
  • Hindi
  • Hmong
  • Hungarian
  • Icelandic
  • Igbo
  • Indonesian
  • Irish
  • Italian
  • Japanese
  • Javanese
  • Kannada
  • Kazakh
  • Khmer
  • Korean
  • Kurdish (Kurmanji)
  • Kyrgyz
  • Lao
  • Latin
  • Latvian
  • Lithuanian
  • Luxembourgish
  • Macedonian
  • Malagasy
  • Malay
  • Malayalam
  • Maltese
  • Maori
  • Marathi
  • Mongolian
  • Myanmar (Burmese)
  • Nepali
  • Norwegian
  • Pashto
  • Persian
  • Polish
  • Portuguese
  • Punjabi
  • Romanian
  • Russian
  • Samoan
  • Scots Gaelic
  • Serbian
  • Sesotho
  • Shona
  • Sindhi
  • Sinhala
  • Slovak
  • Slovenian
  • Somali
  • Spanish
  • Sundanese
  • Swahili
  • Swedish
  • Tajik
  • Tamil
  • Telugu
  • Thai
  • Turkish
  • Ukrainian
  • Urdu
  • Uzbek
  • Vietnamese
  • Welsh
  • Xhosa
  • Yiddish
  • Yoruba
  • Zulu

Abstract

This is a preliminary study utilizing drug targeting approach for developing sildenafil citrate (SFC) pulmonary delivery system, a first -line for pulmonary arterial hypertension (PAH) treatment and hence reducing the dose and the side effects. The closed melt method was employed for preparing SFC -solid lipid microparticles dispersions (SFC -SLMDs), a nonsolvent technique aid in the production of drug -matrix dispersions with sustained release properties. Glyceryl behenate (GB) (Compritol® 888 ATO) was used as the retarding matrix and the results shown that as its ratio increase there was a decrease in the fine particle fraction, an increase in the drug content and a prolong drug release pattern. The best model fit the release data was Higuchi -Matrix model which indicates drug diffusion -controlled releasing mechanism. Thus, inhaled SFC -SLMDs dry powder will improve PAH treatment via drug localization at low doses and reducing the administration frequency.

References

20 Cites in Article
  1. Lyn Frumkin (2012). The Pharmacological Treatment of Pulmonary Arterial Hypertension.
  2. M -C Chaumais,S Perrin,O Sitbon,G Simonneau,M Humbert,D Montani (2013). Pharmacokinetic Evaluation of Sildenafil as a Pulmonary Hypertension Treatment.
  3. N Labiris,M Dolovich (2003). Pulmonary drug delivery. Part I: Physiological factors affecting therapeutic effectiveness of aerosolized medications.
  4. M Beck -Broichsitter,P Kleimann,T Gessler,W Seeger,T Kissel,T Schmehl (2012). Nebulization Performance of Biodegradable Sildenafil -Loaded Nanoparticles using the Aeroneb ® Pro: Formulation Aspects and Nanoparticle Stability to Nebulization.
  5. Mukta Paranjpe,Christel Müller-Goymann (2014). Nanoparticle-Mediated Pulmonary Drug Delivery: A Review.
  6. M Paranjpe,V Neuhaus,J Finke,C Richter,T Gothsch,A Kwade,S Buttgenbach,A Braun,C Muller -Goymann (2013). In Vitro and Ex Vivo Toxicological Testing of Sildenafil -Loaded Solid Lipid Nanoparticles.
  7. Somchai Sawatdee,Hirihattaya Phetmung,Teerapol Srichana (2013). Sildenafil citrate monohydrate–cyclodextrin nanosuspension complexes for use in metered-dose inhalers.
  8. David Cipolla,Boris Shekunov,Jim Blanchard,Anthony Hickey (2014). Lipid-based carriers for pulmonary products: Preclinical development and case studies in humans.
  9. Ysr Elnaggar,M El-Massik,O Abdallah (2011). Fabrication, Appraisal, and Transdermal Permeation of Sildenafil Citrate-Loaded Nanostructured Lipid Carriers versus Solid Lipid Nanoparticles.
  10. S Jagdale,S Patil,B Kuchekar,A Chabukswar (2011). Preparation and Characterization of Metformin Hydrochloride − Compritol 888 ATO Solid Dispersion.
  11. Michael Tsifansky,Yoon Yeo,Oleg Evgenov,Evangelia Bellas,John Benjamin,Daniel Kohane (2008). Microparticles for Inhalational Delivery of Antipseudomonal Antibiotics.
  12. Adamo Fini,Cristina Cavallari,Francesca Ospitali,M Gonzalez-Rodriguez (2011). Theophylline-Loaded Compritol Microspheres Prepared by Ultrasound-Assisted Atomization.
  13. Zahra Daman,Kambiz Gilani,Abdolhossein Rouholamini Najafabadi,Hamid Eftekhari,Mohammad Barghi (2014). Formulation of inhalable lipid-based salbutamol sulfate microparticles by spray drying technique.
  14. Tarek Ahmed (2014). Preparation of transfersomes encapsulating sildenafil aimed for transdermal drug delivery: Plackett–Burman design and characterization.
  15. Matteo Mezzena,Santo Scalia,Paul Young,Daniela Traini (2009). Solid Lipid Budesonide Microparticles for Controlled Release Inhalation Therapy.
  16. Nispa Seetapan,Piyawan Bejrapha,Wanwisa Srinuanchai,Satit Puttipipatkhachorn,Uracha Ruktanonchai (2010). Nondestructive rheological measurement of aqueous dispersions of solid lipid nanoparticles: effects of lipid types and concentrations on dispersion consistency.
  17. M Üner,G Yener (2007). Importance of Solid Lipid Nanoparticles (SLN) in Various Administration Routes and Future Perspectives.
  18. Abdul Qadir,M Rahman,M Karim,M Akter,S,Bin Awkat,T,Reza Ms (2003). Evaluation of Hydrophobic Materials as Matrices for Controlled -Release Drug Delivery.
  19. Yong Zhang,Meirong Huo,Jianping Zhou,Aifeng Zou,Weize Li,Chengli Yao,Shaofei Xie (2010). DDSolver: An Add-In Program for Modeling and Comparison of Drug Dissolution Profiles.
  20. S Dash,P Murthy,L Nath,P Chowdhury (2010). Kinetic Modeling on Drug Release from Controlled Drug Delivery Systems.

Funding

No external funding was declared for this work.

Conflict of Interest

The authors declare no conflict of interest.

Ethical Approval

No ethics committee approval was required for this article type.

Data Availability

Not applicable for this article.

How to Cite This Article

A. A.Yas. 2014. \u201cPreparation and Evaluation of Inhalable Sustained Release Sildenafil Citrate Solid Lipid Microparticles Dispersions\u201d. Global Journal of Medical Research - B: Pharma, Drug Discovery, Toxicology & Medicine GJMR-B Volume 14 (GJMR Volume 14 Issue B5): .

Download Citation

Journal Specifications

Crossref Journal DOI 10.17406/gjmra

Print ISSN 0975-5888

e-ISSN 2249-4618

Version of record

v1.2

Issue date

October 25, 2014

Language
en
Experiance in AR

Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.

Read in 3D

Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.

Article Matrices
Total Views: 4508
Total Downloads: 2073
2026 Trends
Related Research

Published Article

This is a preliminary study utilizing drug targeting approach for developing sildenafil citrate (SFC) pulmonary delivery system, a first -line for pulmonary arterial hypertension (PAH) treatment and hence reducing the dose and the side effects. The closed melt method was employed for preparing SFC -solid lipid microparticles dispersions (SFC -SLMDs), a nonsolvent technique aid in the production of drug -matrix dispersions with sustained release properties. Glyceryl behenate (GB) (Compritol® 888 ATO) was used as the retarding matrix and the results shown that as its ratio increase there was a decrease in the fine particle fraction, an increase in the drug content and a prolong drug release pattern. The best model fit the release data was Higuchi -Matrix model which indicates drug diffusion -controlled releasing mechanism. Thus, inhaled SFC -SLMDs dry powder will improve PAH treatment via drug localization at low doses and reducing the administration frequency.

Our website is actively being updated, and changes may occur frequently. Please clear your browser cache if needed. For feedback or error reporting, please email [email protected]

Request Access

Please fill out the form below to request access to this research paper. Your request will be reviewed by the editorial or author team.
X

Quote and Order Details

Contact Person

Invoice Address

Notes or Comments

This is the heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

High-quality academic research articles on global topics and journals.

Preparation and Evaluation of Inhalable Sustained Release Sildenafil Citrate Solid Lipid Microparticles Dispersions

A. A.Yas
A. A.Yas University of Tikrit
Ali Al - Jipouri
Ali Al - Jipouri

Research Journals